AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 82 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $47,000 | +30.6% | 80,201 | +12.6% | 0.00% | – |
| Q3 2019 | $36,000 | +50.0% | 71,201 | +11.8% | 0.00% | – |
| Q2 2019 | $24,000 | -33.3% | 63,701 | 0.0% | 0.00% | – |
| Q1 2019 | $36,000 | +44.0% | 63,701 | 0.0% | 0.00% | – |
| Q4 2018 | $25,000 | -3.8% | 63,701 | +28.2% | 0.00% | – |
| Q3 2018 | $26,000 | -71.1% | 49,701 | +22.1% | 0.00% | -100.0% |
| Q2 2018 | $90,000 | -41.2% | 40,701 | -9.4% | 0.00% | -50.0% |
| Q1 2018 | $153,000 | -16.4% | 44,901 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $183,000 | +510.0% | 44,901 | -9.7% | 0.00% | – |
| Q3 2017 | $30,000 | +57.9% | 49,701 | +39.2% | 0.00% | – |
| Q2 2017 | $19,000 | -9.5% | 35,700 | +38.9% | 0.00% | – |
| Q1 2017 | $21,000 | -8.7% | 25,700 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $23,000 | +21.1% | 25,700 | 0.0% | 0.00% | – |
| Q3 2016 | $19,000 | -42.4% | 25,700 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $33,000 | – | 25,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $137,000 | 0.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $441,000 | 0.14% |
| CVA Family Office, LLC | 1,137,920 | $535,000 | 0.13% |
| Cypress Capital Management LLC (WY) | 179,525 | $84,000 | 0.10% |
| Willis Investment Counsel | 2,075,840 | $976,000 | 0.05% |
| NTB Financial Corp | 146,100 | $69,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $296,000 | 0.04% |
| Helen Stephens Group, LLC | 117,222 | $55,000 | 0.04% |
| COURIER CAPITAL LLC | 464,356 | $218,000 | 0.02% |
| Western Wealth Management, LLC | 946,800 | $444,000 | 0.02% |